Inactive Instrument

Dyax Corp. Share Price

Equities

US26746E1038

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	Baxalta : Exclusive: Shire prepares to make new bid for Baxalta - source	RE
2015	Wall St. climbs, led by energy, healthcare; Nasdaq 100 hits 15-year high	RE

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Latest news about Dyax Corp.

Baxalta : Exclusive: Shire prepares to make new bid for Baxalta - source	25/15/25	RE
Wall St. climbs, led by energy, healthcare; Nasdaq 100 hits 15-year high	03/15/03	RE
Baxalta : Shire to buy Dyax for $5.9 billion, still wants Baxalta	02/15/02	RE
Baxalta : Shire to buy Dyax for $5.9 billion, still wants Baxalta	02/15/02	RE

Press releases Dyax Corp.

Dyax : Shire Completes Acquisition of Dyax	22/16/22	PR
Dyax : Sets January 21, 2016 As Date of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Shire plc	11/15/11	BU
Dyax : Presents DX-4012 Data at the 2015 American Society of Hematology Annual Meeting	08/15/08	PU
Dyax : Announces Early Termination of Hart-Scott-Rodino Waiting Period	08/15/08	PU
Dyax : Recognized as a "Top Place to Work" by The Boston Globe for Second Year in a Row	08/15/08	PU

More press releases

News in other languages on Dyax Corp.

Baxalta : Shire préparerait une nouvelle offre sur Baxalta	25/15/25
Wall Street portée par les indicateurs, l'énergie et la santé	03/15/03
AbbVie : Wall Street portée par les indicateurs, l'énergie et la santé	03/15/03
Les valeurs à suivre aujourd'hui à Wall Street - Lundi 2 novembre 2015	02/15/02
SHIRE : acquiert l'américain DYAX pour 5,9 milliards de dollars	02/15/02

Managers and Directors - Dyax Corp.

Managers	Title	Age	Since
Colleen Tupper PSD	President	48	-
Jason E. Baranski BRD	Director/Board Member	-	-

Members of the board	Title	Age	Since
Jason E. Baranski BRD	Director/Board Member	-	-
Colleen Tupper PSD	President	48	-

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+3.91%	109B
REGENERON PHARMACEUTICALS, INC.	+10.87%	105B
ARGENX SE	+1.28%	22.25B
BIONTECH SE	-13.14%	22.09B
GENMAB A/S	-7.05%	18.68B
WUXI APPTEC CO., LTD.	-38.36%	17.58B
BEIGENE, LTD.	-10.66%	16.85B
NEUROCRINE BIOSCIENCES, INC.	+3.75%	13.76B
SAREPTA THERAPEUTICS, INC.	+36.70%	12.46B

Bio Therapeutic Drugs

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW